Hans Jörg Kirner

Title: Innovations of Hans Jörg Kirner in Pharmaceutical Chemistry

Introduction

Hans Jörg Kirner is a notable inventor based in Pratteln, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of synthesis methods for statin derivatives. With a total of two patents to his name, Kirner's work is recognized for its innovative approaches to complex chemical processes.

Latest Patents

Kirner's latest patents include a process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives and intermediates thereof. This invention focuses on novel synthesis methods that are suitable for the preparation of statin derivatives. Specifically, it details methods for creating intermediates that involve various hydroxy-protecting groups and carboxy-protecting groups. These advancements are crucial for enhancing the efficiency and effectiveness of statin production.

Career Highlights

Hans Jörg Kirner is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves extensive research and development in the field of drug synthesis, where he applies his expertise to create innovative solutions for pharmaceutical challenges.

Collaborations

Throughout his career, Kirner has collaborated with esteemed colleagues such as Reinhold Öhrlein and Gabriele Baisch. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Hans Jörg Kirner's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts highlight his importance in the field. His work continues to influence the development of effective pharmaceutical solutions.